Sona Nanotech Inc C.SONA

Alternate Symbol(s): SNANF

Healthcare Biotechnology

Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of cetyltrimethylammonium bromide (CTAB), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company is focused on the development of a pre-clinical nanomedical therapy for the treatment of cancer using its biocompatible GNR.

CSE:SONA - Post by User

Sona Nanotech Inc > Rapid Home Test

<< Previous

Bullboard Posts

Next >>

Comment by dart321on Nov 18, 2020 2:17pm

128 Views

Post# 31923755

RE:Rapid Home Test

no it has nothing to do with Sona, the market for this company has always been Canada, Europe and the middle east. The cost of that test is sky high. Nothing that happens in the U.S. has any effect on this company. HC approval is the catalysts that sparks this company, everything else falls into place if HC approves the test. I think everyone would like a crystal ball right about now, lol.

<< Previous

Bullboard Posts

Next >>

Day trading vs. swing trading strategies for small-cap stocks